BioVie Inc (BIVI)

[Trend-Setter]

No worries here! My take, Terren Peizer CEO and BOD Chairman and top caliber Directors has something very significant event (upcoming if not occurred already during quite period prior application to Nasdaq uplisting) that will be publicly released once BIVI starts trading in the Nasdaq Exchange. He for sure has great plans with BioVie like what he did with Catasys, Inc. (Nasdaq: CATS), who is the founder,currently CEO and BOD Chairman. IMO, Terren Peizer saw the potential of BioVie that led him to come aboard on July 2018 by taking a majority stake through Acuitas Group,his personal holding company. He saw Mallinkcrodt, a giant Pharma's interest on BioVie's IP which initiated a patent challenge and will conclude this coming November 2019. Will Mallinkcrodt settle by licensing? OR Buy out BIVI? Only BioVie and Mallinkcrodt are the contenders in getting Terlipressin drug for related liver diseases treatment in the United States.